| 摘要 |
The invention also relates to the use of cyclic Prolyl Glycine ("cyclic PG" or "cPG") and analoges and mimetics thereof, as neuroprotective agents for the tratement and or prevention of neurological disorders including but not limited ot cerebral ischemia or cerebral infaction resulting from a range of phenomena, such as thromboembolic or hemorrhagic stroke, cerebral basospasms, hypoglycemia, cardic arrest, status epilepticus, perinatal asphyxia, anoxia sah as from drowning, pulmonary surger, and cerebral trauma, as well as to the treatment and prevention of chronic neurodenenerative disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, and as anticonvulsants. |
